We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$22.1B
1-Year Est. Return
45.54%
This Fund
S&P 500
This Quarter
Est. Return
+13.16%
1 Year Est. Return
+45.54%
3 Year Est. Return
+139.2%
5 Year Est. Return
+180.26%
10 Year Est. Return
–
AUM
$14.9B
AUM Growth
+$995M
(+7.2%)
Cap. Flow
-$291M
Cap. Flow
% of AUM
-1.95%
Top 10 Holdings %
Top 10 Hldgs %
26.38%
Holding
2,856
New
31
Increased
336
Reduced
1,500
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$128M |
| 2 |
LTHM
Livent Corporation
LTHM
|
+$15M |
| 3 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$12.3M |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$12.2M |
| 5 |
P
Everpure Inc
P
|
+$7.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$28.4M |
| 2 |
Microsoft
MSFT
|
+$25.6M |
| 3 |
NVIDIA
NVDA
|
+$15.2M |
| 4 |
Amazon
AMZN
|
+$11.2M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$10.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.53% |
| 2 | Financials | 12.17% |
| 3 | Healthcare | 11.68% |
| 4 | Consumer Discretionary | 10.99% |
| 5 | Industrials | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Ingevity
NGVT
$2.62B
| $904K | 0.01% |
18,948
| – | – |
|
1352
Federal Agricultural Mortgage
AGM
$2.58B
| $902K | 0.01% |
4,581
-342
| -7% | -$63.6K |
|
1353
Trustmark
TRMK
$2.79B
| $900K | 0.01% |
32,029
| – | – |
|
1354
JELD-WEN Holding
JELD
$164M
| $897K | 0.01% |
42,258
-2,210
| -5% | -$41.3K |
|
1355
Geron
GERN
$982M
| $896K | 0.01% |
271,574
+8,912
| +3% | +$20K |
|
1356
The Bancorp
TBBK
$2.83B
| $896K | 0.01% |
26,769
| – | – |
|
1357
WesBanco
WSBC
$4.07B
| $896K | 0.01% |
30,042
| – | – |
|
1358
OFG Bancorp
OFG
$2.26B
| $893K | 0.01% |
24,265
| – | – |
|
1359
Renasant Corp
RNST
$4B
| $893K | 0.01% |
28,516
| – | – |
|
1360
Teva Pharmaceuticals
TEVA
$42.6B
| $893K | 0.01% |
63,253
| – | – |
|
|
ODP
1361
DELISTED
ODP
ODP
| $892K | 0.01% |
16,806
| – | – |
|
1362
Vera Therapeutics
VERA
$2.08B
| $891K | 0.01% |
20,653
+2,434
| +13% | +$86.7K |
|
1363
Stewart Information Services
STC
$2B
| $890K | 0.01% |
13,686
| – | – |
|
1364
Rocket Pharmaceuticals
RCKT
$367M
| $889K | 0.01% |
33,003
| – | – |
|
1365
Triumph Financial Inc
TFIN
$1.83B
| $889K | 0.01% |
11,203
-560
| -5% | -$42.3K |
|
1366
Supernus Pharmaceuticals
SUPN
$2.78B
| $887K | 0.01% |
26,005
| – | – |
|
1367
InMode
INMD
$876M
| $886K | 0.01% |
40,987
| – | – |
|
1368
Cheesecake Factory
CAKE
$5.84B
| $885K | 0.01% |
24,491
-1,141
| -4% | -$39.7K |
|
1369
Fox Class B
FOX
$24.4B
| $885K | 0.01% |
30,932
-1,135
| -4% | -$31.7K |
|
1370
Photronics
PLAB
$1.97B
| $883K | 0.01% |
31,174
-1,354
| -4% | -$40.3K |
|
1371
Oxford Industries
OXM
$538M
| $883K | 0.01% |
7,852
| – | – |
|
|
BWIN
1372
Baldwin Insurance Group
BWIN
$3B
| $882K | 0.01% |
30,491
-1,394
| -4% | -$36.6K |
|
1373
Agilysys
AGYS
$3.03B
| $878K | 0.01% |
10,422
| – | – |
|
1374
NBT Bancorp
NBTB
$2.78B
| $878K | 0.01% |
23,930
| – | – |
|
1375
Acadia Realty Trust
AKR
$2.84B
| $874K | 0.01% |
51,398
+2,502
| +5% | +$42.1K |
|
Similar funds
BA
FAM
CAM
VARA
CHP
MIC
OAG
MetLife Investment Management's Q1 2024 Portfolio in Review
As of Q1 2024, MetLife Investment Management held 2,856 positions worth $14.9B, up 7.2% from $13.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3.6%. MetLife Investment Management opened 31 new positions and exited 71, leaving the 2,856-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.
- MetLife Investment Management's largest Q1 2024 buy was Flutter Entertainment: 9,898 shares worth $1.98M.
- MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q1 2024, an estimated $128M increase.
- MetLife Investment Management's biggest Q1 2024 reduction was Apple, cutting an estimated $28.4M.
- MetLife Investment Management fully exited Immunogen Inc in Q1 2024, selling an estimated $3.72M.
- MetLife Investment Management's ten largest holdings make up 26% of its $14.9B portfolio in Q1 2024.
- MetLife Investment Management opened 31 new positions and closed 71 in Q1 2024.
- MetLife Investment Management's portfolio value rose 7.2% quarter-over-quarter to $14.9B.
Based on MetLife Investment Management's 13F filing for Q1 2024, filed 14 May 2024.